- Home
- Products
- Clone Screening
- Mammalian Screening
- ClonePix 2 Mammalian Colony Picker
ClonePix 2 Mammalian Colony Picker
A transformative cell line development workflow with automated clone screening and optional monoclonality assurance on day 0*
A complete solution for the automated screening and objective selection of high-value clones across diverse cell types.
The ClonePix® 2 Mammalian Colony Picker is a fully automated system for selecting high-value clones used in antibody discovery and cell line development. Screen more clones in less time with monoclonal verification on day zero, then screen and identify for highest producers in weeks, not months.
Hybridomas, CHO cells, stem cells and other cell types are imaged and selected based on user-defined parameters. Plate handling, barcode reading, and picking are fully integrated, and all data, including images, are saved for downstream analysis. The picker increases the probability of finding optimally produced cell lines and significantly reduces time and labor.
-
Automate antibody discovery and cell line development workflows
ClonePix 2 picker is 10x faster than labor-intensive limiting dilution and FACS. Our sophisticated software and integrated robotics enable a screening speed of > 10,000 clones per day.
-
Select cells with desirable attributes with monoclonality assurance from day 0
Easily screen and select clones based on protein productivity, antigen-specificity, cell viability, and expression levels of tagged recombinant proteins.
-
Increase the probability of identifying high-value clones while eliminating or recovering unstable clones early
Picking accuracy < 1 mm. Robotic picking reduces the risk of colony disturbance. Images of picked clones are stored with data.

ClonePix 2
Features
-
Multiple detection methods
White light identifies and measures clone morphology, size and proximity. Fluorescence indicates expression level and/or specificity. Up to five fluorescent filters are available for multiplexing.
-
Sterility maintenance
A host of sterility features and options including a UV light process for sanitizing the interior of the instrument, as well as pin washing and halogen drying are standard.
-
Integrated plate storage
Includes two storage stacks for source and destination plates, each with a capacity of 10 plates.
-
Discrete colony formation
Semi-solid CloneMediaTM encourages single cells to grow into discreet colonies, and allows for ease of plating. The media allows for a higher density of clones to be screened.
-
Animal-free media and reagents
Chemically defined and animal-free, CloneMedia cell-culture media, is optimized to increase productivity and aid in visualizing secreted antibodies when used with the CloneDetectTM detection agent.
-
Custom automation options*
The Advanced Workflow Engineering Solutions Team can customize the monoclonality system and offer added services such as integrated verification of monoclonality.
*Price, time to deliver, and specifications will vary based on mutually agreed technical requirements. Solution requirements may cause adjustment to standard performance.
Redefine clone screening and selection with transformative cell line development workflows
Empower your team with data analysis that automatically generates a map of clones and their secretion levels from a series of images generated in situ. The ClonePix can also be customized to include image-based monoclonality assurance on day zero.* This means your team can screen in one round and then pick for the highest produces in weeks, not months.
Data analysis and tracking—reveal stable clones faster

Data Analysis
- Automatically generate a 2D map of clones and their secretion levels from a series of images generated in situ
- Screen and select colonies based on:
- – Size, roundness, and proximity to neighbors
- – Ranking according to fluorescence levels
- – Closely placed colonies ignored via user-controlled “proximity” software setting
Data Tracking
All relevant data associated with each colony (including images taken before and after picking along with their picking coordinates) are automatically saved for review and downstream analysis.
Enhanced with monoclonality assurance*
Same ClonePix workflow, now enhanced with high-resolution single-cell imaging capability on day 0

The enhanced ClonePix 2 system can automatically screen and pick clones that are both high producing and monoclonal—all in one system. Screen more clones in less time with monoclonal verification on day zero, then screen and pick for highest produces in less than two weeks.
- Reduce screening time from two rounds to one by providing image-based evidence of clonality
- Rapid Z-stack acquisition feature allows detection of single cells throughout the medium volume, not just a single focal plane, on day 0
- Simplified workflow from single-cell identification and productivity screening with the all-in-one system
Enhanced for stem cell applications*
Identify desirable, clonal stem cell colonies for high-throughput colony screening and picking


High-resolution imaging identifies desirable, clonal stem cell colonies for high-throughput colony screening and picking. Specialized picking pins allow the gentle transfer of adherent, feeder-free cells to high-density plates for clonal expansion and downstream analysis.
- Colony formation - Individual stem cells plated at a low density in 6-well plates divide and develop into colonies. Plating density is kept low to ensure that colonies are derived from a single parent cell.
- Clone screening - Clonally-derived stem cell colonies are identified by their desirable morphological characteristics and are picked from the low-density 6-well plates into higher density 96-well plates to carry forward with the screening. The ClonePix® 2 Mammalian Colony Picker can be customized with high-resolution optics and stem cell-specific pins, allowing this established technology to be leveraged in stem cell workflows.
- Cell growth - Cell growth is determined by monitoring cell division over a given time using label-free imaging.
- Functional screening - In addition to monitoring growth, functional cell-based assays can be performed. This can include assays assessing differentiation potential, pluripotency, ability to form 3D organoids, and other desirable traits.
*Price, time to deliver, and specifications will vary based on mutually agreed technical requirements. Solution requirements may cause an adjustment to standard performance.
Custom solutions are subject to Molecular Devices Custom Products Purchase Terms.
Latest Resources
Applications of ClonePix 2 Mammalian Colony Picker
-
Cell Line Development
Cell line development is a critical step in the process of generating biopharmaceutical molecules, such as monoclonal antibodies. The process often begins with transfecting the host cell type with the DNA encoding the therapeutic protein of interest allowing for random or directed integration of target DNA into the host cell genome. Thousands of clones are screened to isolate the rare high producing cells, a manual and time-consuming process.
Cell surface expression screening
Many proteins that express to the surface of cells are targets for the discovery and development of biopharmaceuticals. For instance, G-protein coupled receptors (GPCRs) are the largest class of cell-surface proteins and are targets for almost 40% of existing drugs. Discovery and selection of high value clones with elevated cell surface expression of GPCRs from a transfected pool of cells can be challenging. The ClonePix 2 System represents an automated method of screening large populations of cells that increases the probability of finding rare high-affinity binder or high producer.
-
Clone productivity screening and titer
An important component in identifying high-value clones is determining productivity of single cell-derived colonies. Screening for productivity using traditional approaches is laborious and time consuming, generally consisting of a multistep process that involves isolating single cells from limiting dilution followed by assessment of titer using ELISA. The ClonePix 2 system combines phenotype selection, single-cell isolation and productivity screening into a single step, resulting in dramatically shorter screening times and increased number of candidates.
Hybridoma Screening
Antibody discovery typically refers to the screening and identification of monoclonal antibodies (mAbs) that target a specific epitope for the diagnosis and treatment of diseases. A common approach to generating monoclonal antibodies involves the fusion of a pre-mitotic cancer cell with a post-mitotic and terminal antibody-expressing B-cell from the spleen. The resulting fused cell is called a hybridoma and has the advantage of producing mAbs while dividing to regenerate itself. Screening hybridomas for binding specificity or productivity can be automated using the ClonePix 2 System.
-
Monoclonal Antibody Discovery
Antibody discovery typically refers to the screening and identification of specific antibodies that target an antigen molecule for the diagnosis and treatment of diseases. The specificity of the antibody is based on its ability to bind the epitope, a unique region on the antigen molecule. Therapeutic antibodies are typically monoclonal, single cell-derived and target a unique epitope region on the antigen. The ClonePix 2 System automates screening and rapid detection of antigen-specific clones from a heterogenous population of cells.
Monoclonality
Cell line development and assurance of monoclonality are critical steps in the process of generating biopharmaceutical molecules, such as monoclonal antibodies. A cell line can be established following the isolation of a single viable cell robustly expressing the protein of interest. A key milestone in this process is documenting evidence of clonality. Documentation of clonality is typically image-based, whereby an image of a single cell is produced and included in regulatory filings.
Specifications & Options of ClonePix 2 Mammalian Colony Picker
Resources of ClonePix 2 Mammalian Colony Picker
Publications
What an innovation centre means for 3D biology
What an innovation centre means for 3D biology
In April 2021, we launched our Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D biology throughout the drug discovery process.…
Blog
[Podcast] Challenges of traditional cell line development and emerging technologies to help regulate monoclonality
[Podcast] Challenges of traditional cell line development and emerging technologies to help regulate monoclonality
Advancements in genetic engineering and synthetic biology have allowed numerous breakthroughs in recent decades. The importance of cell line development needs an honorable mention.…
eBook
How to Implement Colony Picking Workflows with Automation
How to Implement Colony Picking Workflows with Automation
Colony picking represents a powerful tool within the workflow of mammalian cell line development and the study of microbiology.
Blog
The role of Monoclonal Antibodies against COVID-19
The role of Monoclonal Antibodies against COVID-19
Discover why mAbs are key in the fight against SARS-CoV-2 and how the pandemic has shaped their discovery and development pipeline. Over the past three years, the development of…
Blog
COVID-19 Timeline: Diagnostics, Vaccines, and Therapeutic Antibody Development
COVID-19 Timeline: Diagnostics, Vaccines, and Therapeutic Antibody Development
Global research efforts are focused on understanding the SARS-CoV-2 virus in order to develop potential therapies for COVID-19. Join us as we explore a scientific timeline of key…
Brochure
ClonePix 2 Mammalian Colony Picker - Enhanced for Monoclonality Verification
ClonePix 2 Mammalian Colony Picker - Enhanced for Monoclonality Verification
Obtain a comprehensive view of isolated single cells both in XY and Z dimensions on day 0 with the rapid Z-stack acquisition feature, which takes 2,400+ high-resolution, Z-plane imag…
Brochure
Clone screening solutions
Clone screening solutions
Advance your microbial and mammalian clone screening with proven, automated technologies
Blog
The evolution of CHO cells’ role in cell line development
The evolution of CHO cells’ role in cell line development
Since the first approval of recombinant insulin and human growth hormone in the early 1980s, a multitude of recombinant protein therapeutics have been approved by regulatory…
Brochure
ClonePix 2 Mammalian Colony Picker
ClonePix 2 Mammalian Colony Picker
Redefine clone screening and selection with transformative cell line development workflows.
Flyer
High-throughput stem cell screening
High-throughput stem cell screening
Regenerative medicine has the potential to provide cures for some of the world’s most devastating diseases. However, many roadblocks remain when it comes to moving these therapies fr…
Blog
Get to know our Field Applications Scientist: Dwayne Carter
Get to know our Field Applications Scientist: Dwayne Carter
Dwayne Carter gives us a taste of 3D bioprinting, clone screening, and Caribbean cuisine Dwayne Carter is a cell biologist and educator who joined Molecular Devices in November 2020…
Blog
Life sciences technology predictions for 2021
Life sciences technology predictions for 2021
For over 30 years, Molecular Devices has been at the forefront of technological advances which have contributed to significant scientific breakthroughs. To kick off the new year, we…
eBook
Accelerate vaccine development
Accelerate vaccine development
Immunology is now, more than anytime in recent history, one of the top fields of research. Monoclonal antibodies (mAbs) continue to enjoy intense interest as potential therapeutics.…
eBook
Optimize your high-value cell lines
Optimize your high-value cell lines
During the last decade, production of monoclonal antibodies (mAbs) and recombinant proteins using mammalian cells has led to a boom in the introduction of biotherapeutic proteins to…
Scientific Poster
Reducing the Timeline for Isolating Stable CHO DG44 Clones Producing High Titers of Monoclonal Antibody
Reducing the Timeline for Isolating Stable CHO DG44 Clones Producing High Titers of Monoclonal Antibody
CloneSelect Imager system produces objective, quantitative, and consistent results in less time to overcome the challenges associated with conventional cell confluence techniques.…
Scientific Poster
Accelerated one-step screening and selection of PER.C6® clones using ClonePix technology
Accelerated one-step screening and selection of PER.C6® clones using ClonePix technology
In this poster, we present data demonstrating that CloneMedia-PER.C6 supports the growth of cells into discrete colonies that can be imaged, ranked and picked using the ClonePix plat…
Scientific Poster
Rapid High-Throughput Screening and Selection for Clonal Populations of Therapeutic Protein/Antibody Producer Cells and Reporter Cell-Lines, Using Fluorescence Cell Based Assay Techniques
Rapid High-Throughput Screening and Selection for Clonal Populations of Therapeutic Protein/Antibody Producer Cells and Reporter Cell-Lines, Using Fluorescence Cell Based Assay Techniques
This PDF file explores ClonePix FL Technology which is based on the culture of mammalian cell lines in semisolid media originating from one single parent cell.
Scientific Poster
Automated Screening of High Producer HEK293F Clones and Analysis of Post-Translational Modifications of Secreted Proteins
Automated Screening of High Producer HEK293F Clones and Analysis of Post-Translational Modifications of Secreted Proteins
Production of best tolerated therapeutics is the core competence of Octagene. Haemophilia patients are treated lifelong with drugs to prevent bleeding. The daily risk of potential in…
Scientific Poster
Assessing Monoclonality Under Screening of Mammalian Cell Lines by ClonePix FL
Assessing Monoclonality Under Screening of Mammalian Cell Lines by ClonePix FL
Isolation of candidate mammalian cell clones by limited dilution, ring cloning or simply manual collection of colonies is a time consuming, resource intensive and costly procedure th…
Scientific Poster
High Throughput Screening and Selection of Stable High Secreting Clones
High Throughput Screening and Selection of Stable High Secreting Clones
Isolation of mammalian cell clones by limited dilution, ring cloning or simply manual collection of colonies is a time consuming, resource intensive and costly procedure that is pron…
Scientific Poster
High Throughput Screening and Selection of Clonal Populations of Reporter Cell Lines, using Fluorescence Cell Based Assay Techniques
High Throughput Screening and Selection of Clonal Populations of Reporter Cell Lines, using Fluorescence Cell Based Assay Techniques
Advances in cell culture techniques are facilitating development of novel screening assays which enable drug discovery programmes to rely on cell-based assays for high-throughput scr…
Scientific Poster
Rapid Screening and Selection of Stable High Producing Clones
Rapid Screening and Selection of Stable High Producing Clones
Screening cell populations for stable, high producing clones is a key rate-limiting step in the development and production of new protein therapeutics.
Customer Breakthrough
The Fred Hutch Cancer Research Center uses the ClonePix 2 system to efficiently screen and isolate positive hybridoma clones
The Fred Hutch Cancer Research Center uses the ClonePix 2 system to efficiently screen and isolate positive hybridoma clones
The Antibody Technology Shared Resource at the Fred Hutch Cancer Research Center offers custom antibody development to academic and industrial research groups. Their unique multiplex…
Scientific Poster
Bypassing the Need for High Throughput Processing in Cell Line Development: Rapid, Selective in Situ Cell Screening by Phosphopeptide Recognition
Bypassing the Need for High Throughput Processing in Cell Line Development: Rapid, Selective in Situ Cell Screening by Phosphopeptide Recognition
Animal cell culture technology has been thrust to the forefront of the biopharmaceutical industry because of the superior fidelity of mammalian cells in producing clinically relevant…
Brochure
Reagents and Supplies
Reagents and Supplies
Molecular Devices offer products and unrivaled solutions that utilize imaging & intelligent image analysis to support basic research, pharmaceutical & biotherapeutic developm…
Infographic
The Evolution of CHO Cells' Role in Cell Line Development
The Evolution of CHO Cells' Role in Cell Line Development
Check out the evolution timeline of CHO cells from CHO-ori to CHO-K1SV. Read about the properties of CHO cells that make them ideal for cell line development.
Scientific Poster
Rapid Selective in Situ Screening of Hybridomas in Semi-Solid Medium
Rapid Selective in Situ Screening of Hybridomas in Semi-Solid Medium
Explore a simple one-step hybridoma selective secretion assay for detecting and isolating antigen-specific, IgG-secreting hybridoma clones in as little as 8 days from fusion with min…
Scientific Poster
Integration of Automated Colony Picking into Fast Track Cell Line Development Process
Integration of Automated Colony Picking into Fast Track Cell Line Development Process
Download this PDF to learn about fast track cell Line development process with integrated automated colony picker.
Scientific Poster
Rapid Selection and Development of GPCR Expressing Mammalian Cell Lines using Novel ClonePix Technology
Rapid Selection and Development of GPCR Expressing Mammalian Cell Lines using Novel ClonePix Technology
Learn how you can screen for hihgly expressing GPCRs cells using ClonePix 2 system.
Scientific Poster
Rapid Development of a Serum-Free, Suspension-Adapted CHO Cell Production Process
Rapid Development of a Serum-Free, Suspension-Adapted CHO Cell Production Process
Download PDF to explore the process for developing serum-free CHO cell line.
Application Note
Rapid and efficient selection of high producing mammalian cells secreting non-mAb proteins
Rapid and efficient selection of high producing mammalian cells secreting non-mAb proteins
The technology in ClonePix Systems removes the need for serial dilution or cell-sorting techniques. It allows monoclonal populations of high-secreting cells to be established in a much…
Application Note
Using ClonePix System to assess monoclonality
Using ClonePix System to assess monoclonality
The ClonePix System was developed to overcome many of the drawbacks typically associated with isolating choice mammalian cell clones, during screening and selection of secretory cell…
Application Note
Rapid automated selection of mammalian cell colonies by cell surface protein expression
Rapid automated selection of mammalian cell colonies by cell surface protein expression
The ability to select cells based on surface protein expression is of great use in establishing cell lines expressing the receptor(s) of interest for downstream phenotyping/genotyping…
Application Note
Rapid selection and development of GPCR expressing mammalian cell lines using novel ClonePix Technology
Rapid selection and development of GPCR expressing mammalian cell lines using novel ClonePix Technology
Discovery and selection of high expressing GPCR clones from a transfected pool of cells can be challenging with regards to cell-line development. The technology in ClonePix 2 Systems…
Application Note
Enhanced development of virus-specific hybridomas using ClonePix and CloneSelect Imager Technologies
Enhanced development of virus-specific hybridomas using ClonePix and CloneSelect Imager Technologies
The ClonePix System was employed in the high-throughput screening of hundreds of sub-cloned colonies from parental hybridoma material (historically parental line yields were less than…
Brochure
Accelerate Cell Line Development
Accelerate Cell Line Development
Explore PDF to learn how you can accelerate your cell line development and get to your high value hits faster.


Stable Cell Line Development Workflow

Hybridoma Workflow

Selection of high producing mammalian cells secreting non-mAb proteins workflow - SynBioBeta Lightning Talk

Optimized workflow for rapid identification of neutralizing antibodies against viral particles

Identification and Selection of GPCR Cell Lines with ClonePix 2

ClonePix 2
Number of Citations*: 423
Latest Citations: For a complete list, please click here .
*Source: https://scholar.google.com/
- Dated: Jan 01, 2022Publication Name: Cancer Immunoprevention - Methods in Molecular Biology
Monoclonal Antibodies Generation: Updates and Protocols on Hybridoma Technology
Since its inception in 1975, the hybridoma technology revolutionized science and medicine, facilitating discoveries in almost any field from the laboratory to the clinic. Many technological advancements have been developed since then, to create these “magical bullets.” Phage and yeast display libraries expressing the variable heavy and light… View moreSince its inception in 1975, the hybridoma technology revolutionized science and medicine, facilitating discoveries in almost any field from the laboratory to the clinic. Many technological advancements have been developed since then, to create these “magical bullets.” Phage and yeast display libraries expressing the variable heavy and light domains of antibodies, single B-cell cloning from immunized animals of different species including humans or in silico approaches, all have rendered a myriad of newly developed antibodies or improved design of existing ones. However, still the majority of these antibodies or their recombinant versions are from hybridoma origin, a preferred methodology that trespass species barriers, due to the preservation of the natural functions of immune cells in producing the humoral response: antigen specific immunoglobulins. Remarkably, this methodology can be reproduced in small laboratories without the need of sophisticate equipment. In this chapter, we will describe the most recent methods utilized by our Monoclonal Antibodies Core Facility at the University of Texas–M.D. Anderson Cancer Center. During the last 10 years, the methods, techniques, and expertise implemented in our core had generated more than 350 antibodies for various applications.
- Dated: Dec 01, 2017Publication Name: Journal of Immunological Methods
Sequential screening by ClonePix FL and intracellular staining facilitate isolation of high producer cell lines for monoclonal antibody manufacturing
Screening and characterization of cell lines for stable production are critical tasks in identifying suitable recombinant cell lines for the manufacture of protein therapeutics. To aid this essential function we have developed a methodology for the selection of antibody expressing cells using fluorescence based ClonePix FL colony isolation and… View moreScreening and characterization of cell lines for stable production are critical tasks in identifying suitable recombinant cell lines for the manufacture of protein therapeutics. To aid this essential function we have developed a methodology for the selection of antibody expressing cells using fluorescence based ClonePix FL colony isolation and flow cytometry analysis following intracellular staining for immunoglobulin G (IgG). Our data show that characterization of cells by flow cytometry early in the clone selection process enables the identification of cell lines with the potential for high productivity and helps to eliminate unstable cell lines. We further demonstrate a correlation between specific productivity (qP) and intracellular heavy chain (HC) content with final productivity. The unique combination of screening using ClonePix FL and the flow cytometry approaches facilitated more efficient isolation of clonal cell lines with high productivity within a 15 week timeline and which can be applied across NS0 and CHO host platforms. Furthermore, in this study we describe the critical parameters for the ClonePix FL colony based selection and the associated calculations to provide an assessment of the probability of monoclonality of the resulting cell lines.
Contributors: Gargi Roya, Guillermo Miro-Quesadab, Li Zhuanga, Tom Martina, Jie Zhub, Herren Wua, Marcello Marellia, Michael A.Bowena
Go to article - Dated: Dec 14, 2015Publication Name: 24th European Society for Animal Cell Technology (ESACT) Meeting: C2P2: Cells, Culture, Patients, Products
CHO-DHFR cell line development platform: Application of Clonepix and Automated Mini Bioreactor (AMBR) technologies to meet accelerated timelines
The Holy Grail sought by all Bioprocess Cell Line Development (CLD) groups is achieving high yields from easily-cultured, robustly-growing cells in timelines measured in weeks rather than months. As the first bottleneck in process development, CLD must first birth its product for upstream and downstream groups to initiate their own reproductive… View moreThe Holy Grail sought by all Bioprocess Cell Line Development (CLD) groups is achieving high yields from easily-cultured, robustly-growing cells in timelines measured in weeks rather than months. As the first bottleneck in process development, CLD must first birth its product for upstream and downstream groups to initiate their own reproductive cycles. To facilitate shortened CLD timelines, scientists have turned to new technologies and automation platforms. Emerging high-throughput instrumentation such as Clonepix and Automated MicroBioreactors (AMBR) have been enthusiastically integrated into stable cell line generation platforms; however, application of these methodologies among users is divergent.
Contributors: Venkata R Mangalampalli, Dyane Wycuff, Mingzhong Chen, David Berlinger, Elizabeth H Scheideman, Amritha Menon, Guilia Fabozzi, Althaf Hussain & Richard M Schwartz
Go to article - Dated: May 25, 2014Publication Name: New Biotechnology
High-throughput ClonePix FL analysis of mAb-expressing clones using the UCOE expression system
Therapeutic recombinant monoclonal antibodies (mAbs) are commonly produced by high-expressing, clonal, mammalian cells. Creation of these clones for manufacturing remains heavily reliant on stringent selection and gene amplification, which in turn can lead to genetic instability, variable expression, product heterogeneity and prolonged development… View moreTherapeutic recombinant monoclonal antibodies (mAbs) are commonly produced by high-expressing, clonal, mammalian cells. Creation of these clones for manufacturing remains heavily reliant on stringent selection and gene amplification, which in turn can lead to genetic instability, variable expression, product heterogeneity and prolonged development timelines. Inclusion of cis-acting ubiquitous chromatin opening elements (UCOE™) in mammalian expression vectors has been shown to improve productivity and facilitate high-level gene expression irrespective of the chromosomal integration site without lengthy gene amplification protocols. In this study we have used high-throughput robotic clone selection in combination with UCOE™ containing expression vectors to develop a rapid, streamlined approach for early-stage cell line development and isolation of high-expressing clones for mAb production using Chinese hamster ovary (CHO) cells. Our results demonstrate that it is possible to go from transfection to stable clones in only 4 weeks, while achieving specific productivities exceeding 20 pg/cell/day. Furthermore, we have used this approach to quickly screen several process-crucial parameters including IgG subtype, enhancer-promoter combination and UCOE™ length. The use of UCOE™-containing vectors in combination with automated robotic selection provides a rapid method for the selection of stable, high-expressing clones.
Contributors: Jeff Jia Cheng Hou, Ben S. Hughes, Matthew Smede, Kar Man Leung, Kara Levine, Susan Rigby, Peter P. Gray, Trent P.Munro
Go to article
Related Products & Services of ClonePix 2 Mammalian Colony Picker
Featured Applications

Cell Line Development
Cell line development is a critical step in the process of generating biopharmaceutical molecules,…

Cell surface expression screening
Many proteins that express to the surface of cells are targets for the discovery and development of…

Clone productivity screening and titer
An important component in identifying high-value clones is determining productivity of single cell-…

Hybridoma Screening
Antibody discovery typically refers to the screening and identification of monoclonal antibodies (…

Monoclonal Antibody Discovery
Antibody discovery typically refers to the screening and identification of specific antibodies that…

Monoclonality
Cell line development and assurance of monoclonality are critical steps in the process of…
Customer Breakthrough


SUCCESS STORY
The Fred Hutch Cancer Research Center uses the ClonePix 2 system to efficiently screen and isolate positive hybridoma clones
How can we help advance your next big discovery?
Our highly-qualified teams are on the frontlines with our customers, conducting remote or on-site product demonstrations, webinars, and more to help you solve your tough research challenges. How can we help you today?
I’d like to…
How can we help advance your next big discovery?
Our highly-qualified teams are on the frontlines with our customers, conducting remote or on-site product demonstrations, webinars, and more to help you solve your tough research challenges. How can we help you today?
I’d like to…